glucose, (beta-d)-isomer has been researched along with Thrombopenia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dézsi, L; Fülöp, TG; Hamar, P; Hennies, M; Mészáros, T; Őrfi, E; Rosivall, L; Szebeni, J; Szénási, G | 1 |
| Kornerup, KN; Liu, WL; Page, CP; Pitchford, SC; Salmon, GP | 1 |
| Bolam, JP; Smith, MJ | 1 |
| Mikawa, H; Nakato, H; Shinomiya, K | 1 |
| Dineen, JJ; Finch, SC; Perillie, PE | 1 |
| Chen, J; Huang, F; Li, X; Liu, S; Luo, J; Mei, Q; Mo, Q; Ran, M; Wang, L; Wu, A; Wu, J; Yang, J; Zeng, J; Zhang, C; Zhang, T; Zou, W | 1 |
| Chakravarti, A; Huang, J; Jacob, NK; Song, F; Yadav, M | 1 |
| Brell, J; Chak, A; Dowlati, A; Fu, P; Hoppel, CL; Ingalls, S; Ivy, P; Krishnamurthi, S; Posey, J; Ramanathan, RK; Rath, L; Remick, SC | 1 |
| Alberti, D; Arzoomanian, R; Binger, K; Cleary, J; Dresen, A; Feierabend, C; Marnoccha, R; Merchant, J; Thomas, J; Tutsch, K; Wilding, G | 1 |
| Berg, K; Forero, L; Forouzesh, B; Goetz, A; Hammond, LA; Kuhn, JG; Ochoa-Bayona, JL; Ricart, AD; Rowinsky, EK; Takimoto, CH; Tolcher, AW | 1 |
| Aylesworth, C; Campbell, E; Eckhardt, SG; Felton, S; Hammond, L; Hidalgo, M; Kuhn, J; Patnaik, A; Rizzo, J; Rowinsky, EK; Schwartz, G; Tolcher, AW; Weiss, G | 1 |
4 trial(s) available for glucose, (beta-d)-isomer and Thrombopenia
| Article | Year |
|---|---|
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
Topics: Aged; Antineoplastic Agents; Bile Duct Neoplasms; CA-19-9 Antigen; Carbazoles; Female; Fever; Gallbladder Neoplasms; Glucosides; Humans; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia | 2009 |
Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucosides; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 2002 |
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cisplatin; Drug Interactions; Female; Glucosides; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia; Tomography, X-Ray Computed | 2005 |
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Glucosides; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 2001 |
7 other study(ies) available for glucose, (beta-d)-isomer and Thrombopenia
| Article | Year |
|---|---|
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
Topics: Amphotericin B; Animals; Cholesterol; Complement Activation; Complement C3-C5 Convertases; Complement System Proteins; Drug Hypersensitivity Syndrome; Elapid Venoms; Humans; Hypotension; Leukocytosis; Leukopenia; Liposomes; Nanoparticles; Polyethylene Glycols; Rats; Thrombocytopenia; Zymosan | 2019 |
Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration.
Topics: Adult; Animals; Blood Platelets; Bronchoalveolar Lavage Fluid; Busulfan; CD18 Antigens; Cells, Cultured; Chemokine CCL17; Chemokine CCL22; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Humans; Lipopolysaccharides; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Middle Aged; Neutrophil Activation; Neutrophil Infiltration; Neutrophils; P-Selectin; Peritonitis; Platelet Adhesiveness; Pneumonia; Thrombocytopenia; Young Adult; Zymosan | 2010 |
Anti-inflammatory effects of blood platelets in the rat.
Topics: Animals; Blood Platelets; Carrageenan; Edema; Erythrocytes; Female; Histamine; Inflammation; Rats; Thrombocytopenia; Zymosan | 1979 |
Effect of C3 depletion on the genesis of thrombocytopenia induced in rats by Erysipelothrix rhusiopathiae.
Topics: Animals; Blood Platelets; Complement C3; Complement Pathway, Alternative; Elapid Venoms; Erysipelothrix; Male; Platelet Count; Rats; Rats, Inbred Strains; Serotonin; Thrombocytopenia; Time Factors; Zymosan | 1986 |
Zymosan-induced thrombocytopenia in the rat.
Topics: Animals; Blood Platelets; Chromium Isotopes; Male; Megakaryocytes; Mononuclear Phagocyte System; Phagocytosis; Polysaccharides; Rats; Serum Albumin, Radio-Iodinated; Splenectomy; Thrombocytopenia; Zymosan | 1968 |
Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Topics: Anemia; Animals; Blood Platelets; Glucosides; Megakaryocytes; Mice; Thrombocytopenia; Thrombopoiesis; Thrombopoietin; Zebrafish | 2023 |
Ocimum flavone Orientin as a countermeasure for thrombocytopenia.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Cell Differentiation; Dietary Supplements; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Glucosides; Humans; Mice; Ocimum sanctum; Phytochemicals; Thrombocytopenia; Thrombopoiesis | 2018 |